Viewing Study NCT01342094


Ignite Creation Date: 2025-12-25 @ 1:47 AM
Ignite Modification Date: 2026-02-22 @ 2:15 AM
Study NCT ID: NCT01342094
Status: COMPLETED
Last Update Posted: 2015-07-10
First Post: 2011-04-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: DE-111 Against Timolol Ophthalmic Solution 0.5%
Sponsor: Santen Pharmaceutical Co., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Open Angle Glaucoma View
None Ocular Hypertension View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Primary open angle glaucoma or ocular hypertension View